
Clavulanate lithium
CAS No. 61177-44-4
Clavulanate lithium ( Clavulanic acid lithium )
产品货号. M26653 CAS No. 61177-44-4
克拉维酸锂是一种 β-内酰胺酶抑制剂。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥316 | 有现货 |
![]() ![]() |
10MG | ¥518 | 有现货 |
![]() ![]() |
25MG | ¥915 | 有现货 |
![]() ![]() |
50MG | ¥1393 | 有现货 |
![]() ![]() |
100MG | ¥2066 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称Clavulanate lithium
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述克拉维酸锂是一种 β-内酰胺酶抑制剂。
-
产品描述Clavulanate lithium is an inhibitor of β-lactamase.(In Vitro):Combination of Clavulanate lithium with beta-lactam antibiotics prevents microbial lactamases from inactivating antibiotics, but when administered alone has weak antimicrobial activity against most organisms, causing relatively slow growth inhibition.
-
体外实验Cell Viability Assay Cell Line:L. pneumophila NCTC 1119 Concentration:0.25 mg/L, 0.5 mg/L, 1 mg/L Incubation Time:0-35 hours Result:Caused a relatively slow inhibition of growth.
-
体内实验——
-
同义词Clavulanic acid lithium
-
通路GPCR/G Protein
-
靶点Antibacterial
-
受体CDC25C
-
研究领域——
-
适应症——
化学信息
-
CAS Number61177-44-4
-
分子量205.09
-
分子式C8H8LiNO5
-
纯度>98% (HPLC)
-
溶解度In Vitro:?H2O : 33.33 mg/mL (162.51 mM)
-
SMILES[Li+].[H][C@@]12CC(=O)N1[C@@H](C([O-])=O)\C(O2)=C\CO
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Jing L, et al. Identification of highly potent and selective Cdc25 protein phosphatases inhibitors from miniaturization click-chemistry-based combinatorial libraries. Eur J Med Chem. 2019 Sep 14;183:111696.
产品手册




关联产品
-
ClpP inhibitor M21
ClpP抑制剂M21是ClpP的非竞争性抑制剂,IC50为41.42 uM。
-
Ceratotoxin A
Ceratotoxin A, a 29-residue peptide isolated from the accessory gland secretion fluid, with strong anti-bacterial activity.
-
Levofloxacin Hydroch...
盐酸左氧氟沙星杂质 AI 是喹诺酮类化合物之一,具有广谱抗菌作用。